FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313894086> ?p ?o ?g. }

• W4313894086 endingPage "1324" @default.
• W4313894086 startingPage "1315" @default.
• W4313894086 abstract "Extravasation of circulating tumor cells (CTCs) from the vasculature is a key step in cancer metastasis. CTCs bind to cell adhesion molecules (CAMs) expressed by endothelial cells (ECs) for flow arrest prior to extravasation. While a number of EC-expressed CAMs have been implicated in facilitating CTC binding, this work investigated the efficacy of inhibiting cancer cell binding to human lung microvascular ECs via antibody blocking of E-selectin using antibody-functionalized gold nanoshells (NS). The antibody-functionalized gold NS were synthesized using both directional and non-directional antibody conjugation techniques with variations in synthesis parameters (linker length, amount of passivating agents, and ratio of antibodies to NS) to gain a better understanding of these properties on the resultant hydrodynamic diameter, zeta potential, and antibody loading density. We quantified the ability of E-selectin antibody-functionalized NS to bind human lung microvascular endothelial cells (HMVEC-Ls) under non-inflamed and inflamed (TNF-α) conditions to inhibit binding of triple-negative MDA-MB-231s. E-selectin-targeted NS prepared using non-directional conjugation had higher antibody loading than those prepared via directional conjugation, resulting in the conjugates having similar overall binding to HMVEC-Ls at a given antibody concentration. E-selectin-targeted NS reduced MDA-MB-231 binding to HMVEC-Ls by up to 41% as determined using an in vitro binding assay. These results provide useful insights into the characteristics of antibody-functionalized NS prepared under different conditions while also demonstrating proof of concept that these conjugates hold potential to inhibit CTC binding to ECs, a critical step in extravasation during metastasis." @default.
• W4313894086 created "2023-01-10" @default.
• W4313894086 creator A5009466065 @default.
• W4313894086 creator A5009635744 @default.
• W4313894086 creator A5029729155 @default.
• W4313894086 creator A5042372768 @default.
• W4313894086 creator A5057541356 @default.
• W4313894086 date "2023-01-09" @default.
• W4313894086 modified "2023-10-14" @default.
• W4313894086 title "E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells" @default.
• W4313894086 cites W1911760093 @default.
• W4313894086 cites W1969927812 @default.
• W4313894086 cites W1996634424 @default.
• W4313894086 cites W2000654400 @default.
• W4313894086 cites W2015374851 @default.
• W4313894086 cites W2023994044 @default.
• W4313894086 cites W2035809194 @default.
• W4313894086 cites W2050622829 @default.
• W4313894086 cites W2056514358 @default.
• W4313894086 cites W2060465115 @default.
• W4313894086 cites W2070086300 @default.
• W4313894086 cites W2075318716 @default.
• W4313894086 cites W2090110748 @default.
• W4313894086 cites W2095596359 @default.
• W4313894086 cites W2104101394 @default.
• W4313894086 cites W2109718292 @default.
• W4313894086 cites W2118605519 @default.
• W4313894086 cites W2128071642 @default.
• W4313894086 cites W2136586539 @default.
• W4313894086 cites W2144107278 @default.
• W4313894086 cites W2148694942 @default.
• W4313894086 cites W2155329472 @default.
• W4313894086 cites W2157453847 @default.
• W4313894086 cites W2165273651 @default.
• W4313894086 cites W2167460696 @default.
• W4313894086 cites W2330313351 @default.
• W4313894086 cites W2402636472 @default.
• W4313894086 cites W244584656 @default.
• W4313894086 cites W2530365357 @default.
• W4313894086 cites W2616918494 @default.
• W4313894086 cites W2884089350 @default.
• W4313894086 cites W2915166060 @default.
• W4313894086 cites W2971326475 @default.
• W4313894086 cites W2979291688 @default.
• W4313894086 cites W3160501996 @default.
• W4313894086 cites W3164995299 @default.
• W4313894086 doi "https://doi.org/10.1021/acsanm.2c04967" @default.
• W4313894086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37789828" @default.
• W4313894086 hasPublicationYear "2023" @default.
• W4313894086 type Work @default.
• W4313894086 citedByCount "1" @default.
• W4313894086 countsByYear W43138940862023 @default.
• W4313894086 crossrefType "journal-article" @default.
• W4313894086 hasAuthorship W4313894086A5009466065 @default.
• W4313894086 hasAuthorship W4313894086A5009635744 @default.
• W4313894086 hasAuthorship W4313894086A5029729155 @default.
• W4313894086 hasAuthorship W4313894086A5042372768 @default.
• W4313894086 hasAuthorship W4313894086A5057541356 @default.
• W4313894086 hasConcept C121608353 @default.
• W4313894086 hasConcept C123012128 @default.
• W4313894086 hasConcept C12554922 @default.
• W4313894086 hasConcept C153911025 @default.
• W4313894086 hasConcept C155619193 @default.
• W4313894086 hasConcept C159654299 @default.
• W4313894086 hasConcept C16224149 @default.
• W4313894086 hasConcept C185592680 @default.
• W4313894086 hasConcept C202751555 @default.
• W4313894086 hasConcept C203014093 @default.
• W4313894086 hasConcept C2779540182 @default.
• W4313894086 hasConcept C502942594 @default.
• W4313894086 hasConcept C54355233 @default.
• W4313894086 hasConcept C55493867 @default.
• W4313894086 hasConcept C86803240 @default.
• W4313894086 hasConcept C95444343 @default.
• W4313894086 hasConcept C96232424 @default.
• W4313894086 hasConceptScore W4313894086C121608353 @default.
• W4313894086 hasConceptScore W4313894086C123012128 @default.
• W4313894086 hasConceptScore W4313894086C12554922 @default.
• W4313894086 hasConceptScore W4313894086C153911025 @default.
• W4313894086 hasConceptScore W4313894086C155619193 @default.
• W4313894086 hasConceptScore W4313894086C159654299 @default.
• W4313894086 hasConceptScore W4313894086C16224149 @default.
• W4313894086 hasConceptScore W4313894086C185592680 @default.
• W4313894086 hasConceptScore W4313894086C202751555 @default.
• W4313894086 hasConceptScore W4313894086C203014093 @default.
• W4313894086 hasConceptScore W4313894086C2779540182 @default.
• W4313894086 hasConceptScore W4313894086C502942594 @default.
• W4313894086 hasConceptScore W4313894086C54355233 @default.
• W4313894086 hasConceptScore W4313894086C55493867 @default.
• W4313894086 hasConceptScore W4313894086C86803240 @default.
• W4313894086 hasConceptScore W4313894086C95444343 @default.
• W4313894086 hasConceptScore W4313894086C96232424 @default.
• W4313894086 hasFunder F4320337351 @default.
• W4313894086 hasFunder F4320337354 @default.
• W4313894086 hasFunder F4320337378 @default.
• W4313894086 hasFunder F4320337390 @default.
• W4313894086 hasIssue "2" @default.
• W4313894086 hasLocation W43138940861 @default.

• next